# Chemed Corp (CHE) Stock Analysis: Unlocking a 31% Upside Potential

- Link: https://www.directorstalkinterviews.com/chemed-corp-che-stock-analysis-unlocking-a-31-upside-potential/4121221818
- Published: 2025-10-20T10:41:19+01:00
- Author: Madison Wilson

Chemed Corp (NYSE: CHE) is a significant player in the healthcare sector, specifically
within the medical care facilities industry. With a market capitalization of $6.42
billion, Chemed is a formidable entity in providing hospice and palliative care 
services, as well as a range of plumbing and related services through its Roto-Rooter
segment. Headquartered in Cincinnati, Ohio, Chemed has built a robust operational
framework to deliver essential services across the United States.

At the current stock price of $440.56, Chemed offers an intriguing investment opportunity,
particularly when considering its recent price change and potential upside. The 
stock has fluctuated within a 52-week range of $412.30 to $619.21, indicating both
volatility and opportunity for those willing to navigate its price movements.

One of the standout factors for prospective investors is the analyst consensus, 
which suggests a target price range of $550.00 to $595.00, with an average target
of $578.50. This positions Chemed with a promising potential upside of approximately
31.31%, a noteworthy figure for investors seeking growth in their portfolios.

Chemed’s valuation metrics paint a nuanced picture. While traditional metrics such
as the trailing P/E and PEG ratios are not available, the forward P/E ratio stands
at 17.33, suggesting moderate expectations for earnings growth. With a high return
on equity of 24.14%, Chemed demonstrates effective management in generating returns
on shareholders’ equity.

Revenue growth for the company has been steady at 3.80%, complemented by a strong
free cash flow of $285 million. This financial health allows Chemed to maintain 
a stable dividend yield of 0.54% with a conservative payout ratio of 10.29%, ensuring
[sustainability](https://www.directorstalkinterviews.com/sustainability-green-stocks-news)
in shareholder returns.

Technical indicators provide additional insights for those considering an investment
in Chemed. The stock is currently trading below both its 50-day and 200-day moving
averages, at $448.42 and $523.07 respectively, which may indicate a potential buying
opportunity for value investors. The Relative Strength Index (RSI) of 35.99 suggests
the stock is approaching oversold territory, potentially signaling a rebound. However,
the MACD and signal line, both in negative territory, merit cautious optimism.

Analyst sentiment is overwhelmingly positive, with four buy ratings and no hold 
or sell recommendations. This consensus reflects confidence in Chemed’s business
model and growth prospects, particularly as the company continues to expand its 
service offerings and geographic reach.

Investors should be mindful of the broader market trends and economic conditions
that could impact Chemed’s performance. However, given its strong fundamentals, 
potential for upside, and favorable analyst ratings, Chemed Corp represents a compelling
opportunity for investors seeking exposure to the healthcare sector with a diversified
business model.

Share on:
